S
Sathishkumar
About Sathishkumar
Data last updated:
Sathishkumar is a Managing Director at Xenia Pharma Private Limited (since 2015). The companies operate in Chemicals and Trading. Xenia Pharma Private Limited reported revenue of ₹31.9 Lakh (FY 2018). Earlier, Sathishkumar was an Additional Director at Ayrin Pharma Private Limited (2013–2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Xenia Pharma Private Limited U74999MH2015PTC262963 | Managing Director | 25 Mar 2015 | 2015 | ₹31.9 Lakh (FY 2018) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ayrin Pharma Private Limited U51397KL2012PTC031171 | Additional Director | 11 Jun 2013 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sathishkumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Remya | 07091416 | Xenia Pharma Private Limited | Director |
| Vaidyanathan Viswanath | 05122947 | Xenia Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sathishkumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sathishkumar
Sathishkumar currently holds 1 directorship: Xenia Pharma Private Limited (Managing Director, since 25 Mar 2015, revenue ₹31.9 Lakh (FY 2018)).
Sathishkumar was first appointed on 11 Jun 2013 as Additional Director at Ayrin Pharma Private Limited. The most recent appointment on record is 25 Mar 2015 at Xenia Pharma Private Limited.
Sathishkumar held 1 earlier board appointment: Ayrin Pharma Private Limited (Additional Director, 11 Jun 2013 to 24 Sep 2014).
The current boards of Sathishkumar's companies include Remya (Xenia Pharma Private Limited), Vaidyanathan Viswanath (Xenia Pharma Private Limited).